TRACON Pharmaceuticals Inc
TCON
Get informed when a big investor buys or sells
+ FollowMarket Cap$109.73K
Close$
$0.29
813.4% upside
Current Fair Value
813.4% upsideUndervalued by 813.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $109,725.00 |
|---|---|
| Enterprise Value | $-6,160,275.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.2 |
| Beta | 1.42 |
| Outstanding Shares | 3,008,090 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | 70.20% |
| Return on Invested Capital | 293.58% |
Valuation & Multiples
| P/E Ratio | -0.01 |
|---|---|
| PEG | 0.03 |
| Price to Sales | 0.03 |
| Price to Book Ratio | -0.03 |
| Enterprise Value to Revenue | -1.93 |
| Enterprise Value to EBIT | 0.84 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data